One of the most common misconceptions surrounding platelet-rich plasma, commonly called PRP, and cell-based therapies is that patients should experience immediate pain relief after treatment.
Unlike a corticosteroid injection or local anesthetic, regenerative procedures are not primarily intended to suppress symptoms immediately. They are designed to influence the biological environment surrounding an injured or degenerative tissue and support the body’s natural repair processes.
Biological healing takes time. Depending on the condition being treated, the severity and duration of the injury, the patient’s overall health, and the rehabilitation plan, improvement may occur gradually over several weeks or months.
PRP contains concentrated platelets and other plasma components obtained from the patient’s own blood. Once activated, platelets release signaling molecules involved in inflammation, tissue repair, blood-vessel formation, and cellular communication. However, PRP preparations vary substantially, and effectiveness is not uniform across every musculoskeletal condition. [1, 2 3]
Cell-based therapies are also not a single standardized treatment. Their composition, processing, cell concentration, tissue source, delivery method, and regulatory status can differ significantly. Patients should therefore be cautious about any clinic promising rapid tissue regeneration or guaranteed outcomes.
Regenerative Medicine Is Not the Same as a Cortisone Injection
Corticosteroid injections are generally used to reduce inflammation and pain. Some patients experience relatively rapid symptom relief because corticosteroids suppress inflammatory pathways. PRP is intended to work differently.
Rather than simply shutting down inflammation, PRP may modify the inflammatory and healing environment through the release of growth factors, cytokines, and other signaling molecules. These biological processes do not necessarily translate into immediate pain relief.
The Stages of Healing
Although the timing differs among tissues and injuries, connective-tissue healing is often described in three overlapping phases: inflammation, proliferation, and remodeling.
The Inflammatory Phase
The inflammatory phase begins shortly after tissue injury or treatment and commonly lasts for several days.
Platelets and immune cells release chemical signals that help organize the early repair response. These signals attract cells involved in clearing damaged material and preparing the area for tissue reconstruction.
Some inflammation is therefore a normal and necessary component of healing. The goal is not uncontrolled inflammation, but a coordinated biological response.
Following PRP or another injection-based regenerative procedure, patients may experience temporary soreness, mild swelling, stiffness, tenderness at the injection site, or a short-term increase in familiar symptoms. The intensity varies. Some patients experience very little discomfort, while others have several days of increased soreness.
The Proliferative Phase
During the proliferative phase, which generally unfolds over the following weeks, fibroblasts and other repair cells begin producing extracellular-matrix components, including collagen.
New blood vessels may develop, and the injured tissue begins forming a repair matrix. This newly produced tissue is not immediately as organized or mechanically strong as mature connective tissue.
Patients may begin noticing reduced pain or improved function during this period, but recovery is rarely linear. Good days and temporary symptom flares can occur as activity levels increase.
The Remodeling Phase
The remodeling phase may continue for several months.
During this period, collagen fibers reorganize, mature, and align in response to carefully controlled mechanical loading. The repair tissue may gradually become better able to tolerate everyday activities, exercise, and sport-specific demands.
This is one reason progressive rehabilitation is so important. The procedure may help create a biological opportunity for healing, but appropriate movement and loading help guide how the developing tissue adapts.
Because connective-tissue remodeling takes time, patients should not judge the final outcome of a regenerative procedure solely by how they feel during the first few days or weeks.
There is no universal PRP recovery timeline.
The expected response depends on the tissue being treated, the location and severity of the injury, whether the condition is acute or chronic, the presence of arthritis or substantial tissue loss, the PRP preparation, the accuracy of the injection, and the patient’s age and general health.
Smoking, diabetes, metabolic disease, medication use, rehabilitation compliance, and unresolved biomechanical problems may also affect the rate and quality of healing.
A tendon problem, ligament injury, arthritic joint, and muscle injury should not be expected to respond identically.
Some patients notice early improvement in pain. For others, meaningful changes become more apparent after six to twelve weeks. Tissue remodeling and functional improvement may continue for several months.
Why Anti-Inflammatory Medications May Be Restricted
Many regenerative-medicine protocols recommend limiting nonsteroidal anti-inflammatory drugs, or NSAIDs, around the time of PRP treatment. These medications include ibuprofen, naproxen, diclofenac, indomethacin, celecoxib, and meloxicam.
The rationale is that some NSAIDs can alter platelet aggregation, cyclooxygenase activity, inflammatory signaling, or other early biological processes involved in tissue repair.
Medication effects may vary according to the specific drug, dose, duration of use, timing, and method by which platelet function is measured. Reviews have found that some medications may impair certain aspects of platelet function, while other studies have not demonstrated clinically meaningful effects on every PRP-related measurement. [4, 5, 6]
Aspirin or other medications may have been prescribed to reduce the risk of heart attack, stroke, or blood clots. Stopping them without guidance may be dangerous. Medication decisions should be made by the treating physician in coordination with the clinician who prescribed the medication.
Nutrition, Sleep, and General Health Matter
Adequate nutrition provides the amino acids and micronutrients needed to support collagen formation and tissue repair. A patient who is significantly undernourished or consuming inadequate protein may have fewer biological resources available for recovery.
Poorly controlled diabetes, smoking, nicotine use, heavy alcohol consumption, chronic sleep deprivation, obesity, metabolic dysfunction, certain medications, repeated overloading of the injured tissue, and inadequate rehabilitation may all interfere with recovery.
Sleep is particularly important because it supports immune regulation, hormonal balance, pain processing, and physical recovery.
Our other articles
Do anti-inflammatory medications help with healing after regenerative medicine injections?
References
1 Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nature Reviews Rheumatology. 2013 Dec;9(12):721-30.
2 Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. International journal of molecular sciences. 2020 Oct 21;21(20):
3 Fitzpatrick J, Bulsara M, Zheng MH. The effectiveness of platelet-rich plasma in the treatment of tendinopathy: a meta-analysis of randomized controlled clinical trials. The American journal of sports medicine. 2017 Jan;45(1):226-33.
4 Kao DS, Zhang SW, Vap AR. A systematic review on the effect of common medications on platelet count and function: which medications should be stopped before getting a platelet-rich plasma injection?. Orthopaedic Journal of Sports Medicine. 2022 Apr 12;10(4):23259671221088820.
5 Frey C, Yeh PC, Jayaram P. Effects of antiplatelet and nonsteroidal anti-inflammatory medications on platelet-rich plasma: a systematic review. Orthopaedic Journal of Sports Medicine. 2020;8(4):2325967120912841. doi:10.1177/2325967120912841.
6 Leach T, Huang B, Kramer N, Challa S, Winder RP, Challa SC, Winder R. A Review of Platelet-Rich Plasma Use in Patients Taking Non-steroidal Anti-inflammatory Drugs for Guideline Development. Cureus. 2024 Oct 17;16(10).